The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models

R. Joe, Y. Matsumura, A. Siddiqui, J. Foulks, M. Beg, J. Thompson, N. Yamamoto, A. Spira, J. Sarantopoulos, J. Melear, Y. Lou, C. Lebedinsky, J. Li, A. Watanabe, S. Warner

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)S57-S58
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this